Smallpox

News Smallpox

• Biodefense: Anthrax and Smallpox at the Research Forefront

  As the potential threat of biological terrorist attacks continues to command the attention of governments around the globe, anthrax and smallpox remain amongst the most researched diseases in the biodefense industry, states a new report by GBI Research.The company’s latest study shows that anthrax v more

• US Government Exercises Next Part of Bavarian Nordic's Freeze-Dried IMVAMUNE Contract

  Bavarian Nordic A/S announced that BARDA (Biomedical Advanced Research and Development Authority) has exercised the next option under the contract for the development of a freeze-dried version of Bavarian Nordic's IMVAMUNE® smallpox vaccine. The option, which was triggered by the successful complet more

• Study finds H1N1 virus spreads easily by plane

  Viruses love plane travel. They get to fly around the world inside a closed container while their infected carrier breathes and coughs, spreading pathogens to other passengers, either by direct contact or through the air. And once people deplane, the virus can spread to other geographical areas. S more

Publications Smallpox

• Genomic Sequence and Virulence of Clonal Isolates of Vaccinia Virus Tiantan, the Chinese Smallpox Vaccine Strain

  by Qicheng Zhang, Meijuan Tian, Yi Feng, Kai Zhao, Jing Xu, Ying Liu, Yiming Shao Despite the worldwide eradication of smallpox in 1979, the potential bioterrorism threat from variola virus and the ongoing use of vaccinia virus (VACV) as a vector for vaccine development argue for continue more

• Viruses, Vol. 5, Pages 928-953: Protective Effect of Surfactant Protein D in Pulmonary Vaccinia Virus Infection: Implication of A27 Viral Protein

  Vaccinia virus (VACV) was used as a surrogate of variola virus (VARV) (genus Orthopoxvirus), the causative agent of smallpox, to study Orthopoxvirus infection. VARV is principally transmitted between humans by aerosol droplets. Once inhaled, VARV first infects the respiratory tract where it could en more

• Poxvirus Targeting of E3 Ligase β-TrCP by Molecular Mimicry: A Mechanism to Inhibit NF-κB Activation and Promote Immune Evasion and Virulence

  by Daniel S. Mansur, Carlos Maluquer de Motes, Leonie Unterholzner, Rebecca P. Sumner, Brian J. Ferguson, Hongwei Ren, Pavla Strnadova, Andrew G. Bowie, Geoffrey L. Smith The transcription factor NF-κB is essential for immune responses against pathogens and its activation requires the pho more

Market studies Smallpox

• Smallpox – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Smallpox - Pipeline Review, H1 2012', provides an overview of the Smallpox therapeutic pipeline. This report provides information on the therapeutic development for Smallpox, complete with latest updates, and special features on late-stage and discontinued pr more

• Smallpox Global Clinical Trials Review, H2, 2012

  Introduction GlobalData's clinical trial report, “Smallpox Global Clinical Trials Review, H2, 2012" provides data on the Smallpox clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Smallpox. It includes an overview of the trial numbers a more

• Smallpox – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Smallpox - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Smallpox, complete with latest updates, and special features on late-stage and discontinue more

Websites Smallpox